# ![@KymeraTx Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::865299019752452096.png) @KymeraTx Kymera Therapeutics

Kymera Therapeutics posts on X about $kymr, kymera, events, ceo the most. They currently have [-----] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: undefined [#](/creator/twitter::865299019752452096/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::865299019752452096/c:line/m:interactions.svg)

- [--] Week [---] -23%
- [--] Month [-----] -94%
- [--] Months [-------] +598%
- [--] Year [-------] +432%

### Mentions: undefined [#](/creator/twitter::865299019752452096/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::865299019752452096/c:line/m:posts_active.svg)

- [--] Week [--] -8.30%
- [--] Month [--] -12%
- [--] Months [--] +217%
- [--] Year [--] +279%

### Followers: [-----] [#](/creator/twitter::865299019752452096/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::865299019752452096/c:line/m:followers.svg)

- [--] Week [-----] -0.06%
- [--] Month [-----] +0.09%
- [--] Months [-----] +2.70%
- [--] Year [-----] +5.80%

### CreatorRank: undefined [#](/creator/twitter::865299019752452096/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::865299019752452096/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance)  [travel destinations](/list/travel-destinations)  [exchanges](/list/exchanges)  [financial services](/list/financial-services) 

**Social topic influence**
[$kymr](/topic/$kymr), [kymera](/topic/kymera), [events](/topic/events), [ceo](/topic/ceo), [health care](/topic/health-care), [the first](/topic/the-first), [morgan stanley](/topic/morgan-stanley), [healthcare](/topic/healthcare), [oral](/topic/oral), [the world](/topic/the-world)

**Top accounts mentioned or mentioned by**
[@nellomainolfi](/creator/undefined) [@guggenheimptnrs](/creator/undefined) [@morganstanley](/creator/undefined) [@jpmorgan](/creator/undefined) [@nasdaqexchange](/creator/undefined) [@danafarber](/creator/undefined) [@wellsfargo](/creator/undefined) [@jefferies](/creator/undefined) [@pipersandler](/creator/undefined) [@stifel](/creator/undefined) [@eurorespsoc](/creator/undefined) [@bradloncar](/creator/undefined) [@biotechtvhq](/creator/undefined) [@asmsnews](/creator/undefined) [@evercoreisi](/creator/undefined) [@oppenheimer](/creator/undefined) [@hcwco](/creator/undefined) [@goldmansachs](/creator/undefined) [@longwoodleaders](/creator/undefined) [@citis](/creator/undefined)

**Top assets mentioned**
[Kymera Therapeutics, Inc. (KYMR)](/topic/$kymr) [Morgan Stanley (MS)](/topic/morgan-stanley) [Goldman Sachs (GS)](/topic/goldman-sachs) [MOLECULE (MOLECULE)](/topic/molecule) [JPMorgan Chase (JPM)](/topic/jp-morgan) [Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Kymera President and CEO @NelloMainolfi will present at the virtual Morgan Stanley 18th Annual Global Healthcare Conference at 5:00 PM ET this Wednesday Sept. [--]. Watch the live webcast of the presentation here: #targetedproteindegradation https://bit.ly/3ipxNj8 https://bit.ly/3ipxNj8"  
[X Link](https://x.com/KymeraTx/status/1305503367041609732)  2020-09-14T13:47Z [----] followers, [--] engagements


"We are excited to welcome Juliet Williams PhD as Kymeras Senior Vice President Head of Biology. Dr. Williams brings [--] years of drug development experience to the Kymera Leadership Team. Welcome Juliet Learn more: https://bit.ly/3nQLMSt https://bit.ly/3nQLMSt"  
[X Link](https://x.com/KymeraTx/status/1389901086488727561)  2021-05-05T11:13Z [----] followers, [--] engagements


"Today at 4:40pm ET @KymeraTx will be participating in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference. Be sure to tune in here: $KYMR https://bit.ly/3prBZDq https://bit.ly/3prBZDq"  
[X Link](https://x.com/KymeraTx/status/1402661199393832962)  2021-06-09T16:17Z [----] followers, [--] engagements


"Thank you @bradloncar for taking the time to discuss the #innovative technologies that enable our skilled #drugdiscovery team to design first-in-class protein degraders with our CEO @NelloMainolfi on @BiotechTVHQ"  
[X Link](https://x.com/KymeraTx/status/1688633724542341120)  2023-08-07T19:30Z [----] followers, [----] engagements


"The @MorganStanley Global Healthcare Conference brings together #biotech thought leaders to discuss critical trends and innovation driving growth in our industry. Our CEO @NelloMainolfi will be participating in a fireside chat today listen here:"  
[X Link](https://x.com/KymeraTx/status/1701554923987415072)  2023-09-12T11:14Z [----] followers, [---] engagements


"Today Chris from our Platform team is presenting a poster at Chemical Biology in the Hub on how were utilizing cutting-edge computational tools and covalently liganding novel E3 ligases to develop next generation #TPD medicines. Learn more about the event:"  
[X Link](https://x.com/KymeraTx/status/1702283492652941653)  2023-09-14T11:29Z [----] followers, [---] engagements


"Today the Watertown News shared a piece on our team's participation in the annual @DanaFarber #JimmyFundWalk raising funds to support cancer research care and resources for patients around the world. Several Kymerians will be walking together in the event this year supporting the patients we work for every day Check out the article & learn how to get involved:"  
[X Link](https://x.com/KymeraTx/status/1704888618882392201)  2023-09-21T16:01Z [----] followers, [---] engagements


"While sampling festive drinks and snacks from around the globe there was some fierce competition among Kymerians at our #Oktoberfest Water Pong Tournament last week #Belong"  
[X Link](https://x.com/KymeraTx/status/1706617535100019049)  2023-09-26T10:31Z [----] followers, [---] engagements


"Our team is presenting at the #AppliedPharmaceuticalAnalysis conference in Boston today on the #innovative modeling and simulation approaches that support our powerful #drugdiscovery engine to generate high-potential programs that are primed for clinical stage development. Learn more about the event:"  
[X Link](https://x.com/KymeraTx/status/1706974509889167578)  2023-09-27T10:10Z [----] followers, [---] engagements


"Dont miss Yi Zhang at the Discovery on Target congress in Boston this week Shes presenting on #innovative computational tools and approaches utilized for the #discovery of KT-474 our heterobifunctional #IRAK4 degrader for the treatment of autoimmune diseases. Learn more: https://bit.ly/3ZGW0YH https://bit.ly/3ZGW0YH"  
[X Link](https://x.com/KymeraTx/status/1707345332986646949)  2023-09-28T10:43Z [----] followers, [---] engagements


"We recently held an event to celebrate #LatinxHispanicHeritageMonth and recognize the contributions of Latinx and Hispanic individuals in our communities and workplaces. Thank you to the organizers for all the great discussions food trivia and presentations to learn more about the Latin American and Hispanic countries represented at @KymeraTx"  
[X Link](https://x.com/KymeraTx/status/1707706381099315227)  2023-09-29T10:38Z [----] followers, [---] engagements


"Our team was proud to have been a part of the @DanaFarber #JimmyFundWalk yesterday and to work with organizations committed to catalyzing critical cancer #research and supporting the patients we work for every day"  
[X Link](https://x.com/KymeraTx/status/1708833638098317548)  2023-10-02T13:17Z [----] followers, [----] engagements


"Today we reported exciting preclinical #oncology data shared at the AACR-NCI-EORTC #Targets23 Congress and the #InternationalMDM2Workshop demonstrating degradation of #MDM2 as a promising approach for the treatment of Acute Myeloid Leukemia and Merkel cell carcinoma. Learn more:"  
[X Link](https://x.com/KymeraTx/status/1713874659664421186)  2023-10-16T11:08Z [----] followers, [----] engagements


"Explore our upcoming investor events in November in our latest press release:"  
[X Link](https://x.com/KymeraTx/status/1719671544832467250)  2023-11-01T11:03Z [----] followers, [---] engagements


"This week Kymerians are presenting posters at the @asmsnews Annual Conference Advanced #proteomics technologies provide deep insights at high resolution and dimensionality and these innovative strategies help power our robust #drugdiscovery engine. #ASMS2024 #TPD #Pioneer"  
[X Link](https://x.com/KymeraTx/status/1797956803696992468)  2024-06-04T11:41Z [----] followers, [---] engagements


"$KYMR Explore our upcoming investor events in September in our latest press release: https://bit.ly/3AIYmOr https://bit.ly/3AIYmOr"  
[X Link](https://x.com/KymeraTx/status/1828755729773105640)  2024-08-28T11:25Z [----] followers, [---] engagements


"This afternoon join the $KYMR team for a fireside chat at the @WellsFargo Annual #Healthcare Conference where they will discuss our recent progress and upcoming milestones. Live webcast available here: https://bit.ly/3Mydp01 https://bit.ly/3Mydp01"  
[X Link](https://x.com/KymeraTx/status/1831289163527668013)  2024-09-04T11:12Z [----] followers, [---] engagements


"Today well discuss our innovation in the #TPD space including whats ahead for Kymera at the @MorganStanley Annual Global #Healthcare Conference. Listen to the live webcast of our fireside chat here: https://bit.ly/4g78MHP https://bit.ly/4g78MHP"  
[X Link](https://x.com/KymeraTx/status/1831652711265099965)  2024-09-05T11:16Z [----] followers, [---] engagements


"We are thrilled that the FDA has cleared our IND application for our first-in-class oral STAT6 degrader KT-621. As the first #TPD company to advance a degrader for #immunology into clinical trials this exciting milestone highlights our commitment to delivering potentially differentiated solutions for patients suffering from immuno-inflammatory diseases and we could not have accomplished this without the hard work of our amazing team. Read the full press release: #RevolutionizingImmunology https://bit.ly/47Y32wo https://bit.ly/47Y32wo"  
[X Link](https://x.com/KymeraTx/status/1843970469592019143)  2024-10-09T11:03Z [----] followers, [----] engagements


"$KYMR #SaveTheDate Join us on October 31st for our quarterly financial results and latest company updates: https://bit.ly/3NCipRG https://bit.ly/3NCipRG"  
[X Link](https://x.com/KymeraTx/status/1849047654317048309)  2024-10-23T11:18Z [----] followers, [---] engagements


"Were at the 7th Annual #TPD & Induced Proximity Summit in #Boston this week Stop by our plenary sessions including one with our CEO @NelloMainolfi where we'll discuss key milestones in the field and how $KYMR is working to reinvent the treatment of human disease with our first-in-class small molecule degrader medicines. #ReinventingMedicine #TPDSummitBoston2024"  
[X Link](https://x.com/KymeraTx/status/1851217646957600968)  2024-10-29T11:00Z [----] followers, [----] engagements


"$KYMR Today we shared our third quarter [----] financial results and highlighted recent company updates and upcoming milestones. Learn more about the progress weve made toward building an industry-leading portfolio of degrader medicines with the potential to transform treatment paradigms: #ReinventingMedicine https://bit.ly/4hvg6NZ https://bit.ly/4hvg6NZ"  
[X Link](https://x.com/KymeraTx/status/1851950720829788241)  2024-10-31T11:33Z [----] followers, [----] engagements


"$KYMR Explore our upcoming investor events in November in our latest press release: https://bit.ly/3AjCeKK https://bit.ly/3AjCeKK"  
[X Link](https://x.com/KymeraTx/status/1853770016698577137)  2024-11-05T12:03Z [----] followers, [---] engagements


"Today we will discuss our groundbreaking work in #immunology including whats ahead for $KYMR at the @GuggenheimPtnrs Inaugural #Healthcare Innovation Conference. Listen to the fireside chat webcast here: https://bit.ly/40IvKzI https://bit.ly/40IvKzI"  
[X Link](https://x.com/KymeraTx/status/1856291366499705115)  2024-11-12T11:02Z [----] followers, [---] engagements


"Join $KYMR CEO @NelloMainolfi for a fireside chat at the @Jefferies London #Healthcare Conference where hell discuss our exciting progress upcoming milestones and vision to #RevolutionizeImmunology for millions of patients around the world. Listen to the live webcast: #JefferiesHealthcare #Biotech #DrugDevelopment https://bit.ly/40H6Y2R https://bit.ly/40H6Y2R"  
[X Link](https://x.com/KymeraTx/status/1859202238788338079)  2024-11-20T11:48Z [----] followers, [---] engagements


"$KYMR Explore our upcoming investor events in December in our latest press release: https://bit.ly/3V5eDEM https://bit.ly/3V5eDEM"  
[X Link](https://x.com/KymeraTx/status/1861380249746817400)  2024-11-26T12:03Z [----] followers, [----] engagements


"Today our CEO @NelloMainolfi will participate in a fireside chat at the @Piper_Sandler Annual #Healthcare Conference where hell discuss the latest developments across our #immunology pipeline and whats ahead for $KYMR. Listen to the live webcast here: https://bit.ly/3ZwQd9I https://bit.ly/3ZwQd9I"  
[X Link](https://x.com/KymeraTx/status/1863924714881626456)  2024-12-03T12:34Z [----] followers, [---] engagements


"Join our CEO @NelloMainolfi for his fireside chat this afternoon at the @EvercoreISI HealthCONx Conference to learn more about our exciting progress this year and upcoming milestones. Live webcast here: #Healthcare #TPD #Immunology $KYMR https://bit.ly/3Vqc7Jo https://bit.ly/3Vqc7Jo"  
[X Link](https://x.com/KymeraTx/status/1864292047525441870)  2024-12-04T12:53Z [----] followers, [---] engagements


"Don't miss our presentation at the 43rd Annual @jpmorgan Healthcare Conference next week Our CEO @NelloMainolfi will present on Kymera's progress and anticipated milestones for this year. Learn more: #JPM2025 $KYMR https://bit.ly/404OWWr https://bit.ly/404OWWr"  
[X Link](https://x.com/KymeraTx/status/1876601758031458620)  2025-01-07T12:08Z [----] followers, [---] engagements


"Today we shared our anticipated milestones and strategy for [----] as we work to #RevolutionizeImmunology with oral small molecule degrader medicines with biologics-like activity. Learn more: Our CEO @NelloMainolfi will provide an overview of our industry-leading pipeline and discuss our vision for [----] and beyond at the @jpmorgan #Healthcare Conference today at 9am PT/12pm ET check out the live webcast here: #TPD #Immunology #Biotech #JPM2025 $KYMR https://bit.ly/3WgEV7v https://bit.ly/4gPeMos https://bit.ly/4gPeMos https://bit.ly/3WgEV7v https://bit.ly/4gPeMos https://bit.ly/4gPeMos"  
[X Link](https://x.com/KymeraTx/status/1879139937468948760)  2025-01-14T12:14Z [----] followers, [----] engagements


"Join the $KYMR team for a fireside chat at the @Oppenheimer Annual #Healthcare #LifeSciences Conference where theyll discuss our exciting progress and upcoming milestones across our industry leading #immunology pipeline. Live webcast here: #OPCOLifeSciences https://bit.ly/4aH1nww https://bit.ly/4aH1nww https://bit.ly/4aH1nww https://bit.ly/4aH1nww"  
[X Link](https://x.com/KymeraTx/status/1889294660922724587)  2025-02-11T12:45Z [----] followers, [---] engagements


"$KYMR #SaveTheDate Join us on February 27th for our quarterly financial results and latest company updates via a new video conference call format: https://bit.ly/43ntlMn https://bit.ly/43ntlMn"  
[X Link](https://x.com/KymeraTx/status/1892545612802933064)  2025-02-20T12:03Z [----] followers, [---] engagements


"$KYMR Explore our upcoming investor events in March in our latest press release: https://bit.ly/4hTy9gN https://bit.ly/4hTy9gN"  
[X Link](https://x.com/KymeraTx/status/1894720084792230304)  2025-02-26T12:04Z [----] followers, [---] engagements


"$KYMR Today we shared our fourth quarter and full year [----] financial results and highlighted recent company updates and upcoming milestones. Learn about how were building an industry leading pipeline of next generation oral small molecule degrader medicines in #immunology with the potential to transform patients lives: #RevolutionizingImmunology https://bit.ly/4gVHXFK https://bit.ly/4gVHXFK"  
[X Link](https://x.com/KymeraTx/status/1895082867366965661)  2025-02-27T12:05Z [----] followers, [----] engagements


"Dont miss our fireside chat at the #TDCowen Annual #Healthcare Conference where our team will discuss the latest developments across our #immunology pipeline of oral degrader medicines. Listen to the live webcast here: $KYMR #Biotech https://bit.ly/4bwDPuD https://bit.ly/4bwDPuD"  
[X Link](https://x.com/KymeraTx/status/1897233392472936751)  2025-03-05T10:31Z [----] followers, [---] engagements


"$KYMR Today our CMO will discuss our groundbreaking work in #immunology including advancements across our industry-leading pipeline and upcoming milestones at the @HCWCO Autoimmune and Inflammatory Disease Conference. Live webcast here: https://bit.ly/3DVvHHO https://bit.ly/3DVvHHO"  
[X Link](https://x.com/KymeraTx/status/1905227405750337754)  2025-03-27T11:56Z [----] followers, [---] engagements


"$KYMR Explore our upcoming investor events in June in our latest press release: https://bit.ly/4mTRstp https://bit.ly/4mTRstp"  
[X Link](https://x.com/KymeraTx/status/1928044565778382956)  2025-05-29T11:03Z [----] followers, [---] engagements


"$KYMR Today our CEO @NelloMainolfi will discuss the latest developments across our industry-leading #immunology pipeline of oral degrader medicines at the @GoldmanSachs Global #Healthcare Conference. Listen to the live webcast here: https://bit.ly/4efKJGh https://bit.ly/4efKJGh"  
[X Link](https://x.com/KymeraTx/status/1932407850548043869)  2025-06-10T12:01Z [----] followers, [---] engagements


"Kymerians brought the creativity to our recent tie-dye event on the patio From bold swirls to vibrant splashes our team turned Kymera swag into fun wearable art and had a blast doing it together. Proud to celebrate #PrideMonth with community and connection #Belong"  
[X Link](https://x.com/KymeraTx/status/1933492024382271695)  2025-06-13T11:49Z [----] followers, [---] engagements


"Today our CEO @NelloMainolfi joins distinguished thought leaders at the @LongwoodLeaders MIT CEO conference to discuss a range of critical topics shaping the biopharma industry and how organizations can cultivate #innovation to advance transformative medicines for patients. Learn more: #longwoodhealthcareleaders https://bit.ly/4n19Dxf https://bit.ly/4n19Dxf"  
[X Link](https://x.com/KymeraTx/status/1934940800065867845)  2025-06-17T11:46Z [----] followers, [---] engagements


"Were excited to announce two partnership updates across our portfolio of novel oral degrader programs both showcasing our innovation in the field of #targetedproteindegradation. Weve entered into a strategic collaboration with Gilead Sciences to accelerate the development and commercialization of our first disclosed molecular glue degrader program targeting CDK2 a high value oncology target with broad treatment potential in areas of significant unmet need. Additionally our partner Sanofi intends to advance KT-485 an oral highly potent and selective development candidate targeting IRAK4 for"  
[X Link](https://x.com/KymeraTx/status/1937831570120827166)  2025-06-25T11:13Z [----] followers, [----] engagements


"We had a blast welcoming students from The LEAH Project and MassBioEd Foundation summer internship for the fourth year in a row It was a privilege to share our STEM career stories and introduce them to the dynamic world of biotechtheir curiosity enthusiasm and thoughtful questions were truly inspiring Thank you to everyone who helped make the day meaningful engaging and fun for the next generation of innovators"  
[X Link](https://x.com/KymeraTx/status/1950601827809997263)  2025-07-30T16:58Z [----] followers, [---] engagements


"$KYMR Today we shared our second quarter [----] financial results and highlighted recent company updates and upcoming milestones. Discover how were advancing an industry leading pipeline of oral small molecule degrader medicines in immunology with the potential to transform patients lives around the world: #RevolutionizingImmunology https://bit.ly/45ju9ko https://bit.ly/45ju9ko"  
[X Link](https://x.com/KymeraTx/status/1954861724126855281)  2025-08-11T11:05Z [----] followers, 18.7K engagements


"Hello from Times Square We are thrilled to ring the opening bell at @NasdaqExchange today in celebration of our 5-year IPO anniversary. $KYMR Watch the moment live this morning: #NasdaqListed #OpeningBell #IPOAnniversary #RevolutionizingImmunology https://www.nasdaq.com/marketsite/bell-ringing-ceremony https://www.nasdaq.com/marketsite/bell-ringing-ceremony"  
[X Link](https://x.com/KymeraTx/status/1958122580914663640)  2025-08-20T11:02Z [----] followers, [---] engagements


"The Kymera team is here and ready to ring the bell $KYMR Welcoming @KymeraTx to the @NasdaqExchange Opening Bell. https://t.co/x258PycWaW Welcoming @KymeraTx to the @NasdaqExchange Opening Bell. https://t.co/x258PycWaW"  
[X Link](https://x.com/KymeraTx/status/1958158212605104237)  2025-08-20T13:24Z [----] followers, [----] engagements


"Whats it really like to ring the @NasdaqExchange opening bell For Kymera it started with a 4am bus ride from Watertown to Times Squarefueled by espresso excitement and an amazing crew of colleagues who made every moment unforgettable. From early morning trivia and raffles on the bus to the thrill of stepping into the Nasdaq production studio this milestone was more than a ceremonyit was a celebration of the groundbreaking science and incredible people who power our journey every day. Check out some behind-the-scenes snapshots from our big morning in NYC and the cheers back home as our team"  
[X Link](https://x.com/KymeraTx/status/1960318321124839467)  2025-08-26T12:28Z [----] followers, [---] engagements


"$KYMR Our CEO @NelloMainolfi and CMO Jared Gollob join industry leaders today at @Citi's Biopharma Back to School Conference to discuss our innovation in the immunology space including whats ahead for Kymera join the live webcast here: https://bit.ly/3JGrBWF https://bit.ly/3JGrBWF"  
[X Link](https://x.com/KymeraTx/status/1963221267722489983)  2025-09-03T12:43Z [----] followers, [---] engagements


"$KYMR Listen to the live webcast of our CEO @NelloMainolfi and CMO Jared Gollob discussing the latest developments across our industry leading #immunology pipeline of oral degraders at the @WellsFargo #Healthcare Conference this morning: https://bit.ly/466OABD https://bit.ly/466OABD"  
[X Link](https://x.com/KymeraTx/status/1963567794340950156)  2025-09-04T11:40Z [----] followers, [---] engagements


"$KYMR Join our CEO @NelloMainolfi and CMO Jared Gollob for a fireside chat at the @MorganStanley Annual Global #Healthcare Conference where theyll discuss the latest progress and upcoming milestones across our industry leading oral #immunology pipeline. Live webcast here: https://bit.ly/3JP13T7 https://bit.ly/3JP13T7"  
[X Link](https://x.com/KymeraTx/status/1965392934909436080)  2025-09-09T12:32Z [----] followers, [---] engagements


"Today our CMO will spotlight our innovation in #immunology at the virtual @Stifel Immunology and Inflammation Forum. Hell share progress across our industry-leading pipeline of oral degraders and highlight key upcoming milestones. Live webcast here: #RevolutionizingImmunology #DrugDevelopment #Biotech https://bit.ly/4mdhdD9 https://bit.ly/4mdhdD9 https://bit.ly/4mdhdD9 https://bit.ly/4mdhdD9"  
[X Link](https://x.com/KymeraTx/status/1967566134061707663)  2025-09-15T12:28Z [----] followers, [---] engagements


"Our team is heading to Paris this week for the #EADVCongress Were excited to connect with fellow innovators in the #dermatology community and share presentations on our groundbreaking work to advance novel oral degrader medicines. Hope to see you there #RevolutionizingImmunology"  
[X Link](https://x.com/KymeraTx/status/1967995018741997829)  2025-09-16T16:52Z [----] followers, [----] engagements


"Whats the value of a little friendly competition with your colleagues Wed say its pricelessand so much fun 💸 Our Finance team recently hosted a Kymera-style social hour with a Price is Right twist.🎯Contestants went head-to-head guessing the costs of biotech-related expenses complete with bonus rounds and surprise activities that kept the energy sky-high. Big congrats to our Head of IT who walked away with the win 🏆 From laughter to learning this event was a great reminder that investing in connection pays off every timebringing our teams closer together and fueling the spirit that drives"  
[X Link](https://x.com/KymeraTx/status/1968669312295526687)  2025-09-18T13:31Z [----] followers, [---] engagements


"We're hiring If you're a clinical leader ready to shape strategy and drive innovation in dermatology and pulmonology we want to hear from you. Apply now and help us redefine what's possible in immuno-inflammatory care: #Hiring #ApplyNow #Careers #ClinicalDevelopment https://bit.ly/4mtbAkn https://bit.ly/4mtbAkn https://bit.ly/4mtbAkn https://bit.ly/4mtbAkn"  
[X Link](https://x.com/KymeraTx/status/1970832827097796869)  2025-09-24T12:48Z [----] followers, [---] engagements


"In celebration of #HispanicHeritageMonth Kymerians came together for an afternoon bursting with culture connection and joy.🎶🍷💃 From vibrant music and delicious food (homemade sangria included) to lively salsa lessons the event was a true reflection of the richness of our community. A special shoutout to Alexia for the fantastic performance that brought incredible energy and heart to the celebration🌟 At Kymera were proud to honor diverse cultures and experiences through employee-led events that create belonging and bring us closer togetherone step (and dance move) at a time.🕺✨ #Belong"  
[X Link](https://x.com/KymeraTx/status/1973067757924077572)  2025-09-30T16:49Z [----] followers, [---] engagements


"This #EczemaAwarenessMonth we join @nationaleczema to #UnhideEczema and elevate the voices of those living with this chronic condition. Were committed to deepening understanding of the burden eczema places on patients from physical symptoms to emotional and social impacts. Through our work we aim to drive meaningful improvements to the standard of care and advance novel oral therapies for those living with eczema. #AtopicDermatitis #Eczema #RevolutionizingImmunology October is #EczemaAwarenessMonth Join us to #UnhideEczema share stories fight stigma & push for better care. Learn more + get"  
[X Link](https://x.com/KymeraTx/status/1973484732429246838)  2025-10-01T20:26Z [----] followers, [---] engagements


"Our team came together for a lively aprsski celebration to wrap up another year of teamwork progress and big accomplishments🎿❄ With curling showdowns DIY snow globes and wellearned toasts the night was filled with winterwonderland fun.🥌 A huge thank you to every Kymerian whose dedication and collaboration propels our mission to advance transformative medicines for patients. Wishing everyone a joyful holiday season✨ #Culture #Belong #HappyHolidays https://twitter.com/i/web/status/2003822236331819308 https://twitter.com/i/web/status/2003822236331819308"  
[X Link](https://x.com/KymeraTx/status/2003822236331819308)  2025-12-24T13:37Z [----] followers, 50.7K engagements


"Today we announced the appointment of Ellen Chiniara JD as Chief Legal Officer & Corporate Secretary. Ellen is a proven leader in the life sciences and joins us from Alexion Pharmaceuticals. Welcome Read more: https://bit.ly/3Gij8DF https://bit.ly/3Gij8DF"  
[X Link](https://x.com/KymeraTx/status/1610609487802687488)  2023-01-04T12:10Z [----] followers, [----] engagements


"$KYMR Explore our upcoming investor events in February in our latest press release: https://bit.ly/4jzFIKJ https://bit.ly/4jzFIKJ"  
[X Link](https://x.com/KymeraTx/status/1884935568372469841)  2025-01-30T12:03Z [----] followers, [---] engagements


"Today our CEO @NelloMainolfi will discuss our groundbreaking work in #immunology including whats ahead for $KYMR this year at the @GuggenheimPtnrs SMID Cap #Biotech Conference. Listen to the live webcast here: https://bit.ly/4hz1YCC https://bit.ly/4hz1YCC"  
[X Link](https://x.com/KymeraTx/status/1887482827270156500)  2025-02-06T12:45Z [----] followers, [---] engagements


"Our KT-621 BroADen study for adults with moderate to severe #AtopicDermatitis the most common form of #Eczema is underway. Learn more: #ClinicalTrial #BroADen http://www.broadenclinicaltrial.com http://www.broadenclinicaltrial.com"  
[X Link](https://x.com/KymeraTx/status/1924851115637555581)  2025-05-20T15:34Z [----] followers, [---] engagements


"Were excited to announce positive results from our Phase [--] healthy volunteer trial of KT-621 our investigational first-in-class oral STAT6 degrader. The data surpassed our target product profile exceeding our expectations. As the first reported clinical data for a STAT6-targeted medicine this represents a significant milestone and de-risks our current and future studies in atopic dermatitis and asthma patients. This breakthrough in a key disease pathway in #immunology positions us well on the path to advance oral medicines with biologics-like profiles for diseases that affect millions of"  
[X Link](https://x.com/KymeraTx/status/1929494180071420257)  2025-06-02T11:03Z [----] followers, [----] engagements


"Our recently announced first-in-human data for KT-621 our investigational first-in-class oral STAT6 degrader unlocks game changing potential for the industry and for patients. In his latest blog hear from our Founder & CEO @NelloMainolfi on how this milestone moment reinforces Kymeras strategy and ability to advance revolutionary oral medicines with biologics-like profiles: #RevolutionizingImmunology #PatientImpact #Immunology #STAT6 #TPD https://bit.ly/44bmuFA https://bit.ly/44bmuFA"  
[X Link](https://x.com/KymeraTx/status/1932773366890401965)  2025-06-11T12:14Z [----] followers, [----] engagements


"Today our VP Clinical Development will present at the @FOCISimmunology Annual Meeting on KT-621 our investigational first-in-class oral STAT6-targeted medicine and our commitment to advancing novel oral medicines with biologics-like profiles. Learn more: #RevolutionizingImmunology #STAT6 #FOCIS2025 https://bit.ly/44ku9Ac https://bit.ly/44ku9Ac"  
[X Link](https://x.com/KymeraTx/status/1938200331852136632)  2025-06-26T11:39Z [----] followers, [---] engagements


"Were proud to announce late-breaking oral presentations at the @eadv and @EuroRespSoc Congresses featuring KT-621 our investigational first-in-class oral STAT6 degrader and the first STAT6-targeted medicine in clinical development. These presentations underscore the potential of our oral degraders to reshape treatment paradigms in #immunology for patients around the world. Looking at the #EADVCongress this week were: -Presenting a late-breaking oral presentation on the KT-621 Phase [--] Healthy Volunteer data -Sharing new preclinical data in an eposter -Hosting our first company booth come visit"  
[X Link](https://x.com/KymeraTx/status/1968270028014305654)  2025-09-17T11:05Z [----] followers, [----] engagements


"Were thrilled to be featured in a late-breaking oral presentation at the @EuroRespSoc Congress next week. Our VP of Clinical Development will present on KT-621 our investigational first-in-class oral STAT6 degrader and the first STAT6-targeted medicine in clinical development #RevolutionizingImmunology #STAT6 #ERSCongress #ERS2025 https://twitter.com/i/web/status/1971540106583462391 https://twitter.com/i/web/status/1971540106583462391"  
[X Link](https://x.com/KymeraTx/status/1971540106583462391)  2025-09-26T11:39Z [----] followers, [---] engagements


"🎣 Sun sea and shared stories our annual employee-organized fishing trip off the coast of Gloucester MA was a reel success🐠☀ This tradition isnt just about the catch its about connection. Every year we cast off to celebrate the end of summer strengthen our bonds and create unforgettable memories together. From first-timers to seasoned anglers everyone belongs on this boat.🛥 Check out some of the highlights below were already hooked on planning next years voyage #Belong #Culture #EmployeeExperience"  
[X Link](https://x.com/KymeraTx/status/1978071169006723358)  2025-10-14T12:11Z [----] followers, [----] engagements


"Thank you @BioCentury and @SelinaMKoch for featuring our Founder & CEO @NelloMainolfi on the #BioCenturyShow. In this episode Nello discusses the science and strategy of #TargetedProteinDegradationits unique catalytic mechanism ability to reach historically undrugged targets and the challenges and opportunities that come with translating a new modality into meaningful therapies. He also highlights Kymeras industry-leading work in immunology where oral degraders like KT-621 our STAT6 degrader can unlock new possibilities for millions of patients. Listen to the full episode here:"  
[X Link](https://x.com/KymeraTx/status/1978957010767855851)  2025-10-16T22:51Z [----] followers, [---] engagements


"Excited to be a part of @dermsquared's [----] Fall Clinical Dermatology Conference in Las Vegas this week Well be showcasing our recent poster presentations and connecting with attendees at our exhibit hall table. Stop by to meet the team and explore how were leading the way in #immunology innovation with oral degrader therapies. #RevolutionizingImmunology #TargetedProteinDegradation #Dermatology #FallClinical25 #FC25"  
[X Link](https://x.com/KymeraTx/status/1980978937854320708)  2025-10-22T12:45Z [----] followers, [---] engagements


"Today we shared new preclinical data for KT-579 our first-in-class oral IRF5 degrader in two posters at the @ACRheum Convergence Annual Meeting. IRF5 is a high value historically undrugged target that unlocks key biological pathways implicated in disease pathology. The data shared at #ACR25 underscore KT-579s compelling preclinical profile and its potential to offer a transformative oral treatment option for multiple rheumatic and autoimmune diseases. Learn more in our recent press release and view the posters here: #RevolutionizingImmunology https://bit.ly/48On5zL https://bit.ly/48On5zL"  
[X Link](https://x.com/KymeraTx/status/1982765505858420839)  2025-10-27T11:05Z [----] followers, [---] engagements


"Today our Head of Research will be presenting at the @HansonWade TPD & Induced Proximity Summit on our industry-leading oral immunology portfolio. She'll highlight KT-579 our first-in-class oral IRF5 degrader with the potential to address multiple immuno-inflammatory diseases. #RevolutionizingImmunology #TPDSummit #TargetedProteinDegradation"  
[X Link](https://x.com/KymeraTx/status/1983183410525778360)  2025-10-28T14:45Z [----] followers, [---] engagements


"Hear from Ryan Camire Scientist Immunology on how our unique approach and innovative research engine are enabling us to address historically undrugged targets in validated signaling pathways like IRF5 a master regulator of immunity. #ICYMI: Explore our latest #ACR25 posters on KT-579 our first-in-class oral IRF5 degrader. This program highlights our commitment to transforming treatment paradigms through novel oral medicines: #RevolutionizingImmunology #IRF5 #TargetedProteinDegradation #Immunology https://bit.ly/48Szv9W https://bit.ly/48Szv9W"  
[X Link](https://x.com/KymeraTx/status/1983493624152101198)  2025-10-29T11:18Z [----] followers, [---] engagements


"We were honored to host the Women in TPD & Induced Proximity annual networking event yesterday This gathering brought together an incredible community committed to strengthening recognizing and supporting leadership and contributions in the field. #WomenInTPD #WomenInSTEM #TargetedProteinDegradation"  
[X Link](https://x.com/KymeraTx/status/1983972593817506038)  2025-10-30T19:01Z [----] followers, [---] engagements


"🎃 Costumes candy & creativity = a spooktacular Kymera #Halloween bash 👻 Our costume contest was all treats no tricks just fang-tastic fun & team spirit Thanks to everyone who brewed up magical looks. When we come together its always magic✨ #Belong #Culture #EmployeeExperience"  
[X Link](https://x.com/KymeraTx/status/1984630882901144036)  2025-11-01T14:37Z [----] followers, [---] engagements


"Today we shared our third quarter [----] financial results and highlighted recent company updates and upcoming milestones. Discover how were advancing an industry leading pipeline of oral small molecule degrader medicines in #immunology with the potential to transform patients lives around the world: #RevolutionizingImmunology https://bit.ly/43fFhyO https://bit.ly/43fFhyO"  
[X Link](https://x.com/KymeraTx/status/1985680072691388804)  2025-11-04T12:06Z [----] followers, [---] engagements


"Today at the @GuggenheimPtnrs Healthcare Innovation Conference our CEO @NelloMainolfi will highlight progress across our industry-leading oral immunology pipeline and discuss key upcoming milestones. Join the live webcast here: #RevolutionizingImmunology $KYMR https://bit.ly/4hM4Ayl https://bit.ly/4hM4Ayl https://bit.ly/4hM4Ayl https://bit.ly/4hM4Ayl"  
[X Link](https://x.com/KymeraTx/status/1987871607260385326)  2025-11-10T13:14Z [----] followers, [---] engagements


"#ICYMI: Earlier today our CMO Jared Gollob spotlighted our groundbreaking work in targeted protein degradation and our vision for transforming #immunology at the @UBS Global Healthcare Conference. Listen to the full webcast here: #RevolutionizingImmunology $KYMR https://bit.ly/4oDR7es https://bit.ly/4oDR7es https://bit.ly/4oDR7es https://bit.ly/4oDR7es"  
[X Link](https://x.com/KymeraTx/status/1987959682200154217)  2025-11-10T19:04Z [----] followers, [---] engagements


"Today at the @Stifel Healthcare Conference our CEO @NelloMainolfi will share how Kymera is driving innovation in #immunology through our industry-leading pipeline of oral degrader programs. Check out the live webcast here: #RevolutionizingImmunology $KYMR https://bit.ly/4hX05Bd https://bit.ly/4hX05Bd https://bit.ly/4hX05Bd https://bit.ly/4hX05Bd"  
[X Link](https://x.com/KymeraTx/status/1988220611861110837)  2025-11-11T12:21Z [----] followers, [---] engagements


"Our community united for Veterans Day to honor those who serve by sending more than [---] thoughtful letters to veterans and active-duty service members through @aMillionThanks. Special thanks to our team members Kris Randy and Brad for making this event possible and to our Kymera colleagues who have served we deeply appreciate your courage dedication and sacrifice. #Belong #VeteransDay"  
[X Link](https://x.com/KymeraTx/status/1988310648821072080)  2025-11-11T18:19Z [----] followers, [---] engagements


"Thrilled to join the Inflammatory Skin Disease Summit this week and connect with the #dermatology community Stop by our poster and table to discover how were shaping the next era of #immunology innovation with novel oral degrader therapies. #ISDS2025 #RevolutionizingImmunology"  
[X Link](https://x.com/KymeraTx/status/1988957884458365228)  2025-11-13T13:11Z [----] followers, [---] engagements


"Tune in shortly Our CMO will discuss our innovative work in #immunology and upcoming milestones across our industry-leading pipeline of oral degraders at the #TDCowen Immunology & Inflammation Summit: #RevolutionizingImmunology $KYMR https://bit.ly/47EgLtH https://bit.ly/47EgLtH"  
[X Link](https://x.com/KymeraTx/status/1988990074831401368)  2025-11-13T15:19Z [----] followers, [---] engagements


"Tomorrow our CEO @NelloMainolfi will share Kymeras vision for transforming treatment paradigms in #immunology and outline progress and upcoming milestones across our industry-leading pipeline of oral degraders at the @Jefferies Global Healthcare Conference in London. Join the live webcast here: #RevolutionizingImmunology #JefferiesHealthcare $KYMR https://bit.ly/4i6w3Ln https://bit.ly/4i6w3Ln"  
[X Link](https://x.com/KymeraTx/status/1990803377437999427)  2025-11-18T15:24Z [----] followers, [---] engagements


"From savoring delicious foods to dancing and singing our recent #Diwali festival of lights celebration brought joy and color to Kymera🪔🎶💃 These moments remind us how special it is to work in a community where every person brings their own rhythm flavor and story - a true reflection of the rich traditions that make our workplace shine.✨ #Belong #Culture #EmployeeExperience https://twitter.com/i/web/status/1991490354663584180 https://twitter.com/i/web/status/1991490354663584180"  
[X Link](https://x.com/KymeraTx/status/1991490354663584180)  2025-11-20T12:54Z [----] followers, [---] engagements


"Were pleased to share that the first patient has been dosed in our BROADEN2 Phase 2b clinical trial evaluating KT-621 our investigational first-in-class oral STAT6-targeted medicine for moderate to severe atopic dermatitis. This milestone underscores our commitment to advancing novel oral therapies for patients. Read the full announcement: #RevolutionizingImmunology #BROADEN2 #AtopicDermatitis #Eczema $KYMR https://bit.ly/3Kk1k0K https://bit.ly/3Kk1k0K"  
[X Link](https://x.com/KymeraTx/status/1993289634462261482)  2025-11-25T12:04Z [----] followers, [----] engagements


"🦃This Thanksgiving we celebrated gratitude in the sweetest way with handwritten notes and Kymerathemed cookies because teamwork is the recipe for success and appreciation is always in season 💌 Were thankful every day for the incredible Kymera team whose dedication drives our mission to advance innovative oral medicines for patients around the world. #Belong #Culture #HappyThanksgiving https://twitter.com/i/web/status/1993743778432078082 https://twitter.com/i/web/status/1993743778432078082"  
[X Link](https://x.com/KymeraTx/status/1993743778432078082)  2025-11-26T18:08Z [----] followers, [---] engagements


"Today at the @Piper_Sandler 37th Annual Healthcare Conference our CEO @NelloMainolfi will discuss Kymera's groundbreaking work in immunology and highlight key upcoming milestones. Live webcast available here: $KYMR #RevolutionizingImmunology https://bit.ly/3KjiLPe https://bit.ly/3KjiLPe"  
[X Link](https://x.com/KymeraTx/status/1995848107180130385)  2025-12-02T13:30Z [----] followers, [---] engagements


"Today at the@Citi [----] Global Healthcare Conference our CMOJared Gollob will share our vision for transforming treatment paradigms in immunology listen to the live webcast $KYMR #RevolutionizingImmunology https://bit.ly/49RjNMS https://bit.ly/49RjNMS"  
[X Link](https://x.com/KymeraTx/status/1996203076253089875)  2025-12-03T13:01Z [----] followers, [---] engagements


"Join our CMO Jared Gollob for his fireside chat at the Evercore 8th Annual Healthcare Conference to learn more about our industry-leading pipeline of oral degrader programs. Join the live webcast #RevolutionizingImmunolgy https://bit.ly/4otrJr8 https://bit.ly/4otrJr8"  
[X Link](https://x.com/KymeraTx/status/1996566174428168554)  2025-12-04T13:04Z [----] followers, [---] engagements


"Were proud to share that Kymera has been named a @BostonGlobe Top Place to Work for the fourth year in a row And its all thanks to our incredible team. Our exceptional people power everything: bold science backed by a culture where everyone can grow collaborate co-create and make a meaningful impact. This recognition reflects the energy and heart our employees bring every day as we work to revolutionize care in immunology. Want to see what makes our community so special Hear directly from the team in the video below. #RevolutionizingImmunology #TopPlacesToWork"  
[X Link](https://x.com/KymeraTx/status/1996701763290775914)  2025-12-04T22:02Z [----] followers, [----] engagements


"@KymeraTx is honored to announce the appointment of @JMaraganore to its Board of Directors. Dr. Maraganore joins the Board after having led Alnylam as founding CEO and Director and transformed the field of RNAi therapeutics for nearly [--] years. Learn more: https://bit.ly/3IdgApF https://bit.ly/3IdgApF"  
[X Link](https://x.com/KymeraTx/status/1483424726445924357)  2022-01-18T13:03Z [----] followers, [--] engagements


"$KYMR Join us on August 11th for our quarterly financial results and latest company updates: https://bit.ly/4oyKqLo https://bit.ly/4oyKqLo"  
[X Link](https://x.com/KymeraTx/status/1952324987110474209)  2025-08-04T11:05Z [----] followers, [---] engagements


"$KYMR Explore our upcoming investor events in September in our latest press release: https://bit.ly/4n0Jr4R https://bit.ly/4n0Jr4R"  
[X Link](https://x.com/KymeraTx/status/1960659398931386450)  2025-08-27T11:03Z [----] followers, [---] engagements


"$KYMR Join us on November 4th for our quarterly financial results and latest company updates: https://bit.ly/47r8qrP https://bit.ly/47r8qrP"  
[X Link](https://x.com/KymeraTx/status/1983127649007309133)  2025-10-28T11:04Z [----] followers, [---] engagements


"$KYMR Explore our upcoming investor events in November in our latest press release: https://bit.ly/4hDyPYp https://bit.ly/4hDyPYp"  
[X Link](https://x.com/KymeraTx/status/1985316759482573311)  2025-11-03T12:02Z [----] followers, [---] engagements


"$KYMR Explore our upcoming investor events in December in our latest press release: https://bit.ly/4oZgnMI https://bit.ly/4oZgnMI"  
[X Link](https://x.com/KymeraTx/status/1992927158214480264)  2025-11-24T12:03Z [----] followers, [---] engagements


"Were excited to announce positive results from our BroADen Phase 1b clinical trial of KT-621 our investigational first-in-class oral STAT6 degrader in patients with moderate to severe atopic dermatitis. The data provide a powerful validation of our industry-leading STAT6 degrader program and help accelerate our goal to deliver novel oral medicines to millions of patients around the world. Our deepest thanks to the patients investigators and the incredible Kymera team whose dedication made this significant milestone possible. Read more about the promising KT-621 data in our press release and"  
[X Link](https://x.com/KymeraTx/status/1998001677601828955)  2025-12-08T12:08Z [----] followers, 15.2K engagements


"Were pleased to share that the FDA has granted Fast Track designation to KT-621 our investigational first-in-class oral STAT6 degrader for the treatment of moderate to severe atopic dermatitis. This designation supports our goal of advancing a novel once-daily oral medicine with the potential to transform treatment paradigms for millions of patients across multiple Type 2-driven inflammatory diseases. Learn more in our recent press release: #RevolutionizingImmunology https://bit.ly/44kXkUJ https://bit.ly/44kXkUJ"  
[X Link](https://x.com/KymeraTx/status/1999087877158842514)  2025-12-11T12:04Z [----] followers, [----] engagements


"With KT-621 our investigational first-in-class oral STAT6 degrader we see the opportunity to reshape the treatment landscape for millions of patients living with Type [--] immuno-inflammatory diseases. In his latest blog our CEO @NelloMainolfi reflects on our journey to translate KT-621 from a novel idea into early clinical impact and how bold thinking paired with rigorous science is opening the door to a new era of possibility. Read the full blog here: #RevolutionizingImmunology https://bit.ly/3KLjiK3 https://bit.ly/3KLjiK3"  
[X Link](https://x.com/KymeraTx/status/2000948672775766369)  2025-12-16T15:18Z [----] followers, [----] engagements


"2025 was a year defined by progress driven by innovative science bold thinking and strong execution in service of what matters most: delivering revolutionary medicines to patients. At Kymera we advanced our novel oral degrader programs deepened our capabilities and translated possibility into measurable progress across our industry-leading immunology pipeline. Grateful to our incredible team for turning scientific promise into impact. Were proud of what weve accomplished together and energized by whats ahead https://twitter.com/i/web/status/2004570731900813333"  
[X Link](https://x.com/KymeraTx/status/2004570731900813333)  2025-12-26T15:11Z [----] followers, [----] engagements


"Were entering the new year with strong momentum building on our scientific and clinical breakthroughs as we advance our mission to revolutionize the treatment of immuno-inflammatory diseases and deliver novel oral medicines for patients around the world. From all of us at Kymera Happy New Year we look forward to continued progress and the milestones ahead in [----]. #RevolutionizingImmunology #HappyNewYear https://twitter.com/i/web/status/2006714926358798596 https://twitter.com/i/web/status/2006714926358798596"  
[X Link](https://x.com/KymeraTx/status/2006714926358798596)  2026-01-01T13:11Z [----] followers, [---] engagements


"Don't miss our presentation at the 44th Annual @jpmorgan Healthcare Conference next week Our CEO @NelloMainolfi will present on Kymera's recent progress and anticipated milestones for [----]. Learn more: #RevolutionizingImmunology #JPM2026 $KYMR https://bit.ly/4pmx43T https://bit.ly/4pmx43T"  
[X Link](https://x.com/KymeraTx/status/2008510361784520997)  2026-01-06T12:06Z [----] followers, [----] engagements


"Were entering [----] with exciting momentum and a clear vision. Kymera is advancing an industry leading portfolio of oral immunology programs as we work toward transforming the treatment of immuno-inflammatory diseases for patients around the world. With KT-621 Phase 2b studies in atopic dermatitis and asthma underway a first-in-human study for KT-579 planned in [----] and continued progress across our early discovery engine and partnered programsdriven by our teams innovation and strong executionwe are well positioned for the year ahead. Learn more in our recent press release and listen to the"  
[X Link](https://x.com/KymeraTx/status/2011047955873022300)  2026-01-13T12:09Z [----] followers, [----] engagements


"Were pleased to share that the first patient has been dosed in our BREADTH Phase 2b clinical trial evaluating KT-621 our investigational first-in-class oral STAT6-targeted medicine for moderate to severe asthma. This milestone reflects our commitment to advancing novel oral therapies with the potential to transform treatment paradigms for patients living with asthma and other immuno-inflammatory diseases. Read the full announcement: #RevolutionizingImmunology #Asthma #BREADTH https://bit.ly/3Z6pfVu https://bit.ly/3Z6pfVu"  
[X Link](https://x.com/KymeraTx/status/2016844647172091934)  2026-01-29T12:03Z [----] followers, [----] engagements


"$KYMR Explore our upcoming investor events in February in our latest press release: https://bit.ly/3ZNnPiK https://bit.ly/3ZNnPiK"  
[X Link](https://x.com/KymeraTx/status/2019019288485761210)  2026-02-04T12:04Z [----] followers, [---] engagements


"$KYMR Tune in tomorrow to hear our CEO @NelloMainolfi discuss our novel approach in immunology and upcoming milestones across our industry-leading pipeline of oral degrader medicines at the @GuggenheimPtnrs Biotech Summit. Listen to the live webcast here: https://bit.ly/4abvxJS https://bit.ly/4abvxJS"  
[X Link](https://x.com/KymeraTx/status/2021207898575995117)  2026-02-10T13:01Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing